Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    No significant content changes were detected; observed differences appear to be minor formatting adjustments that do not affect the study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:25:21.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Dates were added (extending the timeline to 2025–2027) while older dates were removed. This indicates an update to the time-related content without changing core information.
    Difference
    0.3%
    Check dated 2025-10-20T17:10:16.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a new version tag (v3.2.0), replacing the old v3.1.0; this changes the core content and indicates updated operating status information.
    Difference
    1%
    Check dated 2025-10-06T07:57:41.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.0%
    Check dated 2025-09-29T04:37:43.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.
    Difference
    0.1%
    Check dated 2025-09-14T22:23:24.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.1%
    Check dated 2025-09-07T19:39:58.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.